RNA vs lium

lium (SN51) is 27.0× the size of RNA (SN117) by market capitalisation. Over the past 30 days, SN117 is ahead by 5.2 percentage points (SN117 +21.4% against SN51 +16.1%). Their daily returns move very closely together (correlation 0.87 across 23 shared trading days). Both have run at a similar volatility, around 150% annualised.

Correlation: 0.87
Size ratio: 1 : 27.0
Ahead over 30 days: SN117

RNASN117

$1.7900

24h: -0.56%
Market cap: $5.12M
Volume 24h: $865,917
Volatility (ann.): 161%

liumSN51

$27.3500

24h: +3.02%
Market cap: $138.60M
Volume 24h: $1.70M
Volatility (ann.): 140%

SN117 3.6%Share of the two combined market caps96.4% SN51

Performance

SN117SN51

7 days-18.52%-13.99%SN51
30 days+21.37%+16.13%SN117

Correlation

0.87over 23 shared trading days

−1 opposite0 unrelated+1 in step

7d: insufficient data30d: insufficient data90d: insufficient data1y: insufficient data

Measured on daily returns rather than on prices. Two assets that both simply trend upward score near 1.0 on raw prices whether or not they move together, so returns are what answer the question people mean by correlation.

Risk & extremes

Metric	SN117	SN51
Max drawdown (400d)	-28.8%	-19.1%
Risk-adjusted return (90d)	0.13	0.59

Relative strength over 90 days: SN51 outperformed SN117 by 12.1% — measured on the SN117/SN51 ratio, so it holds regardless of market direction.

RNA →lium →